
Halia Therapeutics
Developer of novel therapies designed to improve the lives of patients with inflammatory disorders and neurological diseases. The company advances innovative medicines that target the immune system's ...
Valuation
$0
Share Price
N/A
Total Raised
$56.7M
Last Round
N/A